人工智能与辅助生殖  

Artificial intelligence and assisted reproductive technology

作　　者：乔杰[1] Qiao Jie(Center for Reproductive Medicine,Department of Obstetrics and Gynecology,Peking University Third Hospital,State Key Laboratory of Female Fertility Promotion,National Clinical Research Center for Obstetrics and Gynecology,Beijing100191,China)

机构地区：[1]北京大学第三医院妇产科生殖医学中心、女性生育力促进全国重点实验室、国家妇产疾病临床医学研究中心,北京100191

出　　处：《中华生殖与避孕杂志》2025年第1期1-4,共4页Chinese Journal of Reproduction and Contraception

基　　金：北京研究型病房卓越计划项目(BRWEP2024W0940901001);国家自然科学基金基础科学中心项目(82288102)。

摘　　要：将人工智能(artificial intelligence,AI)整合到人类辅助生殖技术(assisted reproductive technology,ART)中,将是现代医学最具前景的进步之一。ART包括体外受精、卵胞质内单精子注射、胚胎植入前遗传学检测和胚胎冷冻等,传统上需要依赖于临床医生和胚胎学家的专业知识。考虑到这些技术的复杂性,以及不可完全避免的固有主观性,加之临床对更高成功率需求的不断增长,研究人员和临床医生近年来不断在探索AI驱动的解决方案。AI能够处理大量数据、识别模式和进行预测分析,有可能彻底改变人类生殖医学的各个方面——从初始诊断到治疗计划制定,再到胚胎选择和妊娠监测等。本述评探讨了AI在ART中的应用现状,阐述了目前主要进展、挑战,并对未来发展前景进行展望。The integration of artificial intelligence(AI)into human assisted reproductive technology(ART)represents one of the most promising advancements in modern medicine.ART,which include in vitro fertilization,intracytoplasmic sperm injection,preimplantation genetic testing and embryo freezing,have traditionally relied on the expertise of clinicians and embryologists.The inherent subjectivity and complexity of these processes,coupled with the ever-increasing demand for higher success rates,have prompted researchers and clinicians to explore AI-driven solutions.AI,with its capacity to process vast amounts of data,recognize patterns,and make predictive analyses,offers the potential to revolutionize every aspect of human reproduction,from initial diagnosis and treatment planning to embryo selection and pregnancy monitoring.This summary explores the current landscape of AI applications in ART,reviewing key advancements,challenges,and future prospects.

关 键 词：人工智能 生殖技术 辅助 变革 伦理 监管 

分 类 号：TP18[自动化与计算机技术—控制理论与控制工程] R714.8[自动化与计算机技术—控制科学与工程]